Maftivimab Antibody
Maftivimab (REGN3470-3471-3479), also known as Inmazeb, is an FDA-approved monoclonal antibody cocktail targeting the Zaire ebolavirus. It functions as a filovirus inhibitor and is applied in research for studying Ebola virus infection mechanisms, supported by in vitro neutralization and in vivo non-human primate efficacy studies.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2138208 1.0 µg DNA
SGTA sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
